Keyword: Allergan

News

Teva Cuts Jobs, Closes Plants as Woes Deepen

08.08.2017 - As its financial woes continue to deepen, Israeli generics producer Teva is making plans to lay off 7,000 employees and close 15 plants. CEO Yitzhak Peterburg said the company will...

News

Allergan and Novartis Link on NASH

08.05.2017 - Major drug makers Allergan and Novartis are collaborating to test a new combination therapy for non-alcoholic steatohepatitis (NASH), a progressive form of fatty liver disease said...

News

Allergan and Editas Medicine in Eye Disease Pact

20.03.2017 - Allergan has secured exclusive access to Editas Medicine’s genome-editing ocular programs under a strategic research and development agreement. The deal covers early stage, first...

News

Activist Investor Ackman Exits Valeant

15.03.2017 - US activist investor Bill Ackman is pulling the plug on his Pershing Square Capital Management hedge fund’s loss-making engagement in drugmaker Valeant. After the close of trading...

News

Allergan Boosts Esthetics with Zeltiq Buy

22.02.2017 - Allergan’s spending spree shows no sign of stopping. It its latest move, the Ireland- based former US drugmaker has agreed to pay nearly $2.5 billion for Zeltiq Aesthetics, a US...

News

Teva Facing Bribery Charges in Israel

10.02.2017 - Israeli drugmaker – the world’s largest generics producer – has moved into the spotlight again, days after it said it was replacing its CEO Erez Vigodman. According to the Israeli...

News

Pharma Stocks Crash on Trump Pricing Hints

13.01.2017 - American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...

News

Allergan Buys US Chase Pharmaceuticals

24.11.2016 - Irish drugmaker Allergan has beefed up its pipeline for neurodegenerative disorders with the acquisition of US-based Chase Pharmaceuticals. Under the terms of the deal, Allergan...